Archivos De Bronconeumologia最新文献

{"title":"FEV₁Q as a Predictive Metric for Asthma Outcomes.","authors":"Diana Betancor, Jose Maria Olaguibel, Victoria Del Pozo, Maria Jose Alvarez Puebla, Ebymar Arismendi, Blanca Barroso, Irina Bobolea, Blanca Cárdaba, José Antonio Cañas, Javier Domínguez-Ortega, María-Jesús Cruz, Elena Curto, Alberto Garcia de la Fuente, Francisco Jose González-Barcala, Juan-Alberto Luna-Porta, Cesar Martínez-Rivera, Joaquim Mullol, Xavier Muñoz, César Picado, Vicente Plaza, Santiago Quirce, Manuel Jorge Rial, Lorena Soto-Retes, Marcela Valverde-Monge, Ignacio Mahíllo-Fernández, Joaquin Sastre","doi":"10.1016/j.arbres.2025.02.011","DOIUrl":"https://doi.org/10.1016/j.arbres.2025.02.011","url":null,"abstract":"","PeriodicalId":8339,"journal":{"name":"Archivos De Bronconeumologia","volume":" ","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143630128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Are Oxygen and Non-Invasive Ventilation Useful \"Clean Doping Boosters\" for Thoracoabdominal Asynchrony During Exertion in Severe COPD?","authors":"Michele Vitacca, Mara Paneroni","doi":"10.1016/j.arbres.2025.02.012","DOIUrl":"https://doi.org/10.1016/j.arbres.2025.02.012","url":null,"abstract":"","PeriodicalId":8339,"journal":{"name":"Archivos De Bronconeumologia","volume":" ","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143630126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is Obstructive Sleep Apnea in People Without Obesity a Unique Disease?","authors":"Atul Malhotra, Ana Lucia Fuentes, Bradley A Edwards","doi":"10.1016/j.arbres.2025.02.014","DOIUrl":"10.1016/j.arbres.2025.02.014","url":null,"abstract":"","PeriodicalId":8339,"journal":{"name":"Archivos De Bronconeumologia","volume":" ","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143673437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy and Safety of Platelet-Rich Plasma on Bronchopleural Fistula: A Pilot Prospective Cohort Study","authors":"Yongshun Ye ,&nbsp;Tingting Xu ,&nbsp;Jinxia Lin ,&nbsp;Yongna Cai ,&nbsp;Zhuquan Su ,&nbsp;Liya Lu ,&nbsp;Yu Chen ,&nbsp;Changgao Zhong ,&nbsp;Chunli Tang ,&nbsp;Weiquan Xiao ,&nbsp;Haojie Liao ,&nbsp;Shiyue Li ,&nbsp;Xiaobo Chen","doi":"10.1016/j.arbres.2024.06.018","DOIUrl":"10.1016/j.arbres.2024.06.018","url":null,"abstract":"<div><h3>Introduction</h3><div>Bronchopleural fistula (BPF) is associated with high morbidity and mortality rates in patients undergoing pulmonary resections. Surgery, bronchoscopy, and conservative management have their limitations for small fistulas. Platelet-rich plasma (PRP) has regenerative properties, which might be efficient in enhancing tissue recovery and repairing small BPF. This study aimed to investigate efficacy and safety of PRP on BPF.</div></div><div><h3>Methods</h3><div>This is a pilot prospective cohort study. Patients whose fistulas smaller than 4<!--> <!-->mm were enrolled in this study, treated with PRP under bronchoscopy and followed up at 2 weeks and 4–6 weeks after the last PRP treatment. The cure rate, improvement rate and ineffectiveness rate were investigated. The severity of respiratory symptoms was evaluated by modified Medical Research Council dyspnea scale (mMRC) and COPD Assessment Test (CAT). The recurrence of fistula, new infection and mortality rate were examined. Adverse events were documented to explore the safety profile of PRP therapy.</div></div><div><h3>Results</h3><div>A total of 16 patients (mean age, 50.1 years) met the eligibility criteria. The median time from the first PRP treatment to the closure of the fistula was 12.0 (IQR 6.0, 21.5) days. Our findings indicate an effectiveness rate of 87.6%, with 68.8% of cure and 18.8% of improvement, along with significant improvement of respiratory symptoms evaluated by mMRC (<em>P</em> <!-->&lt;<!--> <!-->0.001) and CAT (<em>P</em> <!-->&lt;<!--> <!-->0.001). No recurrent of fistulas, newly developed infection, or death was observed. Adverse events of the procedure were most mild (82.6%) and temporary.</div></div><div><h3>Conclusions</h3><div>PRP is a potential treatment for small BPF and is well tolerated.</div></div>","PeriodicalId":8339,"journal":{"name":"Archivos De Bronconeumologia","volume":"61 3","pages":"Pages 132-137"},"PeriodicalIF":8.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141692568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mucus Plugs as Precursors to Exacerbation and Lung Function Decline in COPD Patients","authors":"Kwang Nam Jin ,&nbsp;Hyo Jin Lee ,&nbsp;Heemoon Park ,&nbsp;Jung-Kyu Lee ,&nbsp;Eun Young Heo ,&nbsp;Deog Kyeom Kim ,&nbsp;Hyun Woo Lee","doi":"10.1016/j.arbres.2024.07.017","DOIUrl":"10.1016/j.arbres.2024.07.017","url":null,"abstract":"<div><h3>Background</h3><div>Mucus plugs identified through chest computed tomography (CT) scans have emerged as potential prognostic factors in chronic obstructive pulmonary disease (COPD). This 5-year longitudinal study investigated their impact on exacerbations and FEV₁ decline.</div></div><div><h3>Methods</h3><div>COPD patients with baseline chest CT and spirometric assessments were categorized based on mucus plug presence. Propensity-score matching yielded balanced groups. Exacerbation rates, time to exacerbation events, hazard ratio (HR) for exacerbations, and annual rates of FEV₁ decline were evaluated. Sensitivity analysis was performed with stratification according to mucus plug scores of 0, 1–2, and ≥3.</div></div><div><h3>Results</h3><div>Among 623 eligible patients, the mucus plug group was 44.3%. Through 1:1 propensity-score matching, each group was comprised of 187 individuals with balanced covariates. The mucus plug group showed higher rates of moderate-to-severe (0.51/year vs. 0.58/year, <em>P</em> <!-->=<!--> <!-->0.035), severe exacerbations (0.21/year vs. 0.24/year, <em>P</em> <!-->=<!--> <!-->0.032), and non-eosinophilic exacerbations (0.45/year vs. 0.52/year, <em>P</em> <!-->=<!--> <!-->0.008). Mucus plugs were associated with increased hazard of moderate-to-severe (adjusted HR<!--> <!-->=<!--> <!-->1.502 [95% CI 1.116–2.020]), severe (adjusted HR<!--> <!-->=<!--> <!-->2.106 [95% CI, 1.429–3.103]), and non-eosinophilic exacerbations (adjusted HR<!--> <!-->=<!--> <!-->1.551 [95% CI, 1.132–2.125]). Annual FEV₁ decline was accelerated in the mucus plug group (<em>β</em>-coefficient<!--> <!-->=<!--> <!-->−62 [95% CI, −120 to −5], <em>P</em> <!-->=<!--> <!-->0.035). Sensitivity analysis showed higher risk of exacerbations and accelerated FEV₁ decline in mucus plug score ≥3 compared to score 0.</div></div><div><h3>Conclusions</h3><div>Mucus plugs are associated with increased risks of exacerbations, particularly non-eosinophilic, and accelerated FEV₁ declines over 5 years. Our study identified the potential prognostic value of mucus plugs on future exacerbation risks and lung function decline trajectories.</div></div>","PeriodicalId":8339,"journal":{"name":"Archivos De Bronconeumologia","volume":"61 3","pages":"Pages 138-146"},"PeriodicalIF":8.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141844660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reproducibility of the Lung Information Needs Questionnaire Via Phone Call Compared With Face-to-face Application in Patients With Chronic Obstructive Pulmonary Disease","authors":"Soraya S. Nohara ,&nbsp;Gerson F. Souza ,&nbsp;Maria E. Leão ,&nbsp;Ana C. Fleury ,&nbsp;José R. Jardim","doi":"10.1016/j.arbres.2024.10.007","DOIUrl":"10.1016/j.arbres.2024.10.007","url":null,"abstract":"","PeriodicalId":8339,"journal":{"name":"Archivos De Bronconeumologia","volume":"61 3","pages":"Pages 166-167"},"PeriodicalIF":8.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A New Method Using Diaphragmatic Ultrasound to Monitor the Work of Breathing During Assisted and Controlled Non-Invasive Ventilation","authors":"Alba Naya-Prieto ,&nbsp;María de los Ángeles Zambrano ,&nbsp;Maria del Pilar Carballosa ,&nbsp;Itziar Fernández Ormaechea ,&nbsp;Carlos López Chang ,&nbsp;Pablo Zazu López ,&nbsp;Pedro Piñero Gutierrez ,&nbsp;María Jesús Rodríguez-Nieto ,&nbsp;Germán Peces-Barba Romero ,&nbsp;Victoria del Pozo ,&nbsp;Sarah Heili-Frades","doi":"10.1016/j.arbres.2024.10.014","DOIUrl":"10.1016/j.arbres.2024.10.014","url":null,"abstract":"","PeriodicalId":8339,"journal":{"name":"Archivos De Bronconeumologia","volume":"61 3","pages":"Pages 170-172"},"PeriodicalIF":8.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142680868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Rare Case of Cypermethrin Poisoning Presenting as Alveolar Hemorrhage: A Case Report","authors":"Ruhsel Cörüt,&nbsp;Şaban Melih Şimşek","doi":"10.1016/j.arbres.2024.11.002","DOIUrl":"10.1016/j.arbres.2024.11.002","url":null,"abstract":"","PeriodicalId":8339,"journal":{"name":"Archivos De Bronconeumologia","volume":"61 3","pages":"Pages 182-183"},"PeriodicalIF":8.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142791003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Screening Tackles the Big Three: The AGILE Alliance","authors":"David F. Yankelevitz ,&nbsp;Matthijs Oudkerk ,&nbsp;Claudia I. Henschke","doi":"10.1016/j.arbres.2024.12.010","DOIUrl":"10.1016/j.arbres.2024.12.010","url":null,"abstract":"","PeriodicalId":8339,"journal":{"name":"Archivos De Bronconeumologia","volume":"61 3","pages":"Pages 129-131"},"PeriodicalIF":8.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of the Impact of Elexacaftor/Tezacaftor/Ivacaftor on Aerobic Capacity in Children With Cystic Fibrosis Aged 6-11 Years: Actual Observations and Clinical Perspectives.","authors":"Margarita Pérez-Ruiz, Mats Te Bos, Patricia Fernández-García, Cristina de Manuel, Ana Morales-Tirado, Alejandro López-Neyra, Marta Ruiz de Valbuena, Margarita Rubio, Verónica Sanz-Santiago","doi":"10.1016/j.arbres.2025.02.010","DOIUrl":"https://doi.org/10.1016/j.arbres.2025.02.010","url":null,"abstract":"<p><strong>Background: </strong>Cystic fibrosis causes exercise limitation due to impaired lung function and other complications, which in turn increases the chance of mortality. CFTR modulators, particularly the elexacaftor/tezacaftor/ivacaftor (ETI) combination, improve lung function in children older than 6 years in real-life studies.</p><p><strong>Objective: </strong>This study aimed to assess the impact of ETI on aerobic capacity in children with CF aged 6-11 years under real-life conditions and to evaluate whether prior CFTR modulator treatment affects these outcomes.</p><p><strong>Methods: </strong>A multicenter, prospective cohort study was conducted with pediatric CF patients. Participants underwent evaluations 6-8 months before ETI (T1), at the start of ETI (T2), and 6-8 months post-treatment (T3). Primary outcomes included cardiorespiratory fitness assessed via peak oxygen consumption (VO₂peak) during a cardiopulmonary exercise test (CPET), and secondary outcomes encompassed lung function, quality of life, physical activity, and functional mobility.</p><p><strong>Results: </strong>Of the 28 patients (mean age 9.02±1.59 years), 19 were ETI-naive, and 9 had prior CFTR modulator treatment. Significant improvements were observed in FEV₁ (p<0.001), and several functional mobility tests (30CST, Stair Climb Test, 10MWT). However, VO₂peak showed no significant changes between T1 and T3. Quality of life scores improved notably in emotional, eating, and respiratory domains, and a slight improvement was noted in physical activity levels (p=0.037).</p><p><strong>Conclusions: </strong>ETI treatment significantly enhances lung function and certain aspects of quality of life and physical fitness in pediatric CF patients. However, it does not significantly alter aerobic capacity (VO₂peak) within the observed period.</p>","PeriodicalId":8339,"journal":{"name":"Archivos De Bronconeumologia","volume":" ","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143668908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}